|
Name and surname:
|
Mgr. Lucia Kováčiková, PhD.
|
|
Document type:
|
Research/art/teacher profile of a person
|
|
The name of the university:
|
Comenius University Bratislava
|
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
| III.a - Occupation-position | III.b - Institution | III.c - Duration |
|---|---|---|
| senior researcher | Institution of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine, SAS | 2021 - present |
| Assistent professor | Comenius University in Bratislava, Facuty of Natural Sciences | 2021 - present |
| researcher | Institution of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine, SAS | 2011 - 2021 |
| Teamleader | Institution of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine, SAS | 2025 - present |
| IV.a - Activity description, course name, other | IV.b - Name of the institution | IV.c - Year |
|---|---|---|
| Protection of animals used for scientific or educational purposes | Institute of Veterinary Education Doctors | 2019 |
| Promoting the quality of social dialogue: English language - Advanced | Implementation Agency of the Ministry of Labour and Social Affairs SR | 2020-2022 |
| V.5.a - Name of the course | V.5.b - Study programme | V.5.c - Degree | V.5.d - Field of study |
|---|---|---|---|
| Testovanie bioaktívnych zlúčenín | Organická a bioorganická chémia | II. | chémia |
| Cvičenia z organickej chémie pre biológov | biológia / medicínska biológia | I. | biológia |
| Seminár z organickej chémie | biológia / medicínska biológia | I. | biológia |
| Výberové cvičenia zo syntézy a identifikácie organických zlúčenín pre biológov | biológia / medicínska biológia | I. | biológia |
| Seminár a cvičenie diplomantov | organická a bioorganická chémia | II. | chémia |
L. Kovacikova, M. Soltesova-Prnova, M. Majekova, A. Bohac, C. Karasu, M. Stefek (2021). Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications. Molecules, 26, 2867. (22 citations)
M. Hlavac, L. Kovacikova, M. Soltesova Prnova, P. Sramel, G. Addova, M. Majekova, G. Hanquet, A. Bohac, M. Stefek (2020). Development of Novel Oxotriazinoindole Inhibitors of Aldose Reductase: Isosteric Sulfur/Oxygen Replacement in the Thioxotriazinoindole Cemtirestat Markedly Improved Inhibition Selectivity. J Med Chem, 63, 369-381. (24 citations)
Kovacikova, L.; Majekova, M.; Stefek, M. (2015).Substituted Pyridoindoles as Biological Antioxidants: Drug Design, Chemical Synthesis, and Biological Activity. Advanced Protocols in Oxidative Stress III. Book Series: Methods in Molecular Biology. (6 citations)
MILÁČKOVÁ, Ivana - ŠOLTÉSOVÁ PRNOVÁ, Marta - MÁJEKOVÁ, Magdaléna - SOTNÍKOVÁ, Ružena - STAŠKO, Michal - KOVÁČIKOVÁ, Lucia - BANERJEE, Sreeparna - VEVERKA, Miroslav - ŠTEFEK, Milan. 2-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent. In Journal of Enzyme Inhibition and Medicinal Chemistry, 2015, vol. 30, no. 1, p. 107-113. (35 citations)
Remko, M.; Bohac, A.; Kovacikova, L. (2011). Molecular structure, pKa, lipophilicity, solubility, absorption, polar surface area, and blood brain barrier penetration of some antiangiogenic agents. Str. Chem. (56 citations)
KOUSAXIDIS, Antonios - PAOLI, Paolo - KOVÁČIKOVÁ, Lucia - GENOVESE, Massimo - SANTI, Alice - ŠTEFEK, Milan - PETROU, Anthi - NICOLAOU, Ioannis. Rational design and synthesis of novel N-benzylindole-based epalrestat analogs as selective aldose reductase inhibitors: An unexpected discovery of a new glucose-lowering agent (AK-4) acting as a mitochondrial uncoupler. In European Journal of Medicinal Chemistry, 2025, vol. 281, art.no. 117035. (2024: 5.9 - IF, Q1 - JCR, 1.142 - SJR, Q1 - SJR). ISSN 0223-5234. Dostupné na: https://doi.org/10.1016/j.ejmech.2024.117035
KOVÁČIKOVÁ, Lucia - GAIKWAD, Sunil - ALMÁŠIOVÁ, Kristína - ALMÁSSY, Ambroz - ADDOVÁ, Gabriela - MÁJEKOVÁ, Magdaléna - HANQUET, Gilles - DOBRIČIĆ, Vladimir - BOHÁČ, Andrej - ŠTEFEK, Milan. Selectivity of N(2)-substituted oxotriazinoindole aldose reductase inhibitors is determined by the interaction pattern with Pro301-Arg312 loop of aldehyde reductase. Medicinal Chemistry Research, 2024, 33, 492-503. https://doi.org/10.1007/s00044-024-03194-3
KOVÁČIKOVÁ, Lucia - ŠOLTÉSOVÁ PRNOVÁ, Marta - BOĎO, Pavol - ŠTEFEK, Milan. Cemtirestat dimerization in liposomes and erythrocytes exposed to peroxyl radicals was reverted by thiol-disulfide exchange with GSH. In Free Radical Research : official journal of the Society for Free Radical Research -European Region, 2024, vol. 58, no. 1, p.1-10. (2023: 3.6 - IF, Q2 - JCR, 0.778 - SJR, Q2 - SJR). ISSN 1071-5762. Dostupné na: https://doi.org/10.1080/10715762.2023.2298852
M. Hlaváč, L. Kováčiková, M. Šoltésová Prnová, G. Addová, G. Hanquet, M. Štefek, A. Boháč (2021) Novel substituted N-benzyl(oxotriazinoindole) inhibitors of aldose reductase exploiting ALR2 unoccupied interactive pocket. Bioorganic & Medicinal Chemistry, 29 115885. (2 citations)
M. Hlavac, L. Kovacikova, M. Soltesova Prnova, P. Sramel, G. Addova, M. Majekova, G. Hanquet, A. Bohac, M. Stefek (2020). Development of Novel Oxotriazinoindole Inhibitors of Aldose Reductase: Isosteric Sulfur/Oxygen Replacement in the Thioxotriazinoindole Cemtirestat Markedly Improved Inhibition Selectivity. J Med Chem, 63, 369-381. (12 citations)
J Med Chem, 2020, 63, 369-381: HAN, Z.F. - QI, G. - ZHU, J.K. - ZHANG, Y.D. - XU, Y. - YAN, K. - ZHU, C.J. - HAO, X. Novel 3,4-dihydroquinolin-2(1 H )-one derivatives as dual inhibitor targeting AKR1B1/ROS for treatment of diabetic complications: Design, synthesis and biological evaluation. In BIOORGANIC CHEMISTRY. ISSN 0045-2068, 2020, vol. 105, art. no. 104428.
STRUCTURAL CHEMISTRY 2011, 22,635-648: Fuchs, K ; Duran, R ; Denys, A ; Bize, PE ; Borchard, G ; Jordan, O: Drug-eluting embolic microspheres for local drug delivery. JOURNAL OF CONTROLLED RELEASE 262, 127-138. DOI10.1016/j.jconrel.2017.07.016
Molecules 2021, 26, 2867: Kumari, P; Kohal, R ; Bhavana (Bhavana); Gupta, GD; Verma, SK: Selectivity challenges for aldose reductase inhibitors: A review on comparative SAR and interaction studies. JOURNAL OF MOLECULAR STRUCTURE 2024, 1318, 139207. DOI10.1016/j.molstruc.2024.139207
European Journal of Medicinal Chemistry, 2021, vol. 223, art. no. 113630. Bernardoni, BL; D'Agostino, I; Scianò, F; La Motta, C: The challenging inhibition of Aldose Reductase for the treatment of diabetic complications: a 2019-2023 update of the patent literature. EXPERT OPINION ON THERAPEUTIC PATENTS 2024, 34, 1085-1104. DOI10.1080/13543776.2024.2412573.
European Journal of Medicinal Chemistry, 2025, vol. 281, art.no. 117035. ZOGNJANI, Blinera - NIXHA, Arleta Rifati - DURAN, Hatice Esra - ARSLAN, Mustafa - YILDIZTEKIN, Gizem - ECE, Abdulilah - TURKES, Cueneyt. N-substituted phthalimide-carboxylic acid hybrids as dual-targeted aldose reductase inhibitors: Synthesis, mechanistic insights, and cancer-relevant profiling. In BIOORGANIC CHEMISTRY. , vol. 163, art. no. 108788. Dostupné na: https://doi.org/10.1016/j.bioorg.2025.108788
2024 Cena Slovenskej akadémie vied za výsledky vedeckovýskumnej práce
2023 ocenená práca Bc.študentky na ŠVK Cenou dekana za chémiu
2009 ocenenie Pfizer Research Award
Spoluriešiteľ 2 patentov:
ŠTEFEK, Milan - KOVÁČIKOVÁ, Lucia - ŠOLTÉSOVÁ PRNOVÁ, Marta - ADDOVÁ, Gabriela - BOHÁČ, A. Zlúčenina cemtirestat disulfid, prekurzor inhibítora aldoketoreduktáz, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie : patentová prihláška PP 50074-2020, dátum podania prihlášky: 14.12.2020. Banská Bystrica : Úrad priemyselného vlastníctva Slovenskej republiky, 2020. 25 s. (SK patent, EU patent, CN patent, IN patentová prihláška)
ŠTEFEK, Milan - KOVÁČIKOVÁ, Lucia - MILÁČKOVÁ, Ivana - VEVERKA, Miroslav - ŠVAJDLENKA, Emil - VEVERKOVÁ, Eva. Deriváty kvercetínu, farmaceutická kompozícia s ich obsahom a ich použitie : patentová prihláška PP 5006-2012, dátum podania prihlášky: 29.02.2012, medzinárodné patentové triedenie: CO7D311/30 verzia MPT: 16, CO7D407/12, A61K31/35, A61P3/10, A61P9/10, A61P11/06, A61P13/12, A61P25/00, A61P27/02, A61P27/00, A61P35/00, A61P39/06. Prihlasovateľ: Ústav experimentálnej farmakológie a toxikológie SAV, Dúbravská cesta 9, 841 04 Bratislava, SK. Banská Bystrica : Úrad priemyselného vlastníctva Slovenskej republiky, 2012